Stereotactic Radiotherapy (SRT) versus Whole Brain Radiotherapy (WBRT) in the management of 1-3 brain metastases (BM) originating from a gastrointe...

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter P.S. Lim
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors P.S. Lim1, R. Mir2, M. Harrison2
  • 1Mount Vernon Cancer Centre, Northwood, United Kingdom, /
  • 2Mount Vernon Hospital, Northwood, United Kingdom, /

Abstract

Brain metastasis from a primary GI tumour is rare with reported incidences of less than 10% (1). In the era of advanced diagnostic imaging modalities and improved systemic therapies in GI cancers, the incidence of brain metastases in this population is rising as a consequence. There is increasing evidence to support the use of SRT in treating brain metastases but very few have compared the efficacy of SRT directly with WBRT, especially in GI cancers (2).